4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-011650
EVP, Chief Medical Officer sold 1,306 shares at $12.12 ($15,833)
From the SEC's structured data for this filing
Trades in this filing
Shah Jatin · EVP, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-17 | Sale : show line 1 in the form | −1,306 | $12.12 | $15,833 | 129,450 | D |
| Open-market sales · 1,306 sh · avg $12.12 · $15,833 | ||||||
Loading xslF345X03/doc4.xml…